|
|
 Previous Article | Table of Contents | Next Article 
Full Activity From Human  -Globin Locus Control Region Transgenes
Requires 5 HS1, Distal -Globin Promoter, and 3
-Globin Sequences
Peter Pasceri,
Dylan Pannell,
Xiumei Wu, and
James Ellis
From the Developmental Biology Program, Cancer and Blood Program, and
Blood Gene Therapy Program, Hospital for Sick Children, Toronto,
Ontario, Canada, and the Department of Molecular and Medical Genetics,
University of Toronto, Toronto, Ontario, Canada.
The locus control region (LCR) activates high-level human  -globin
transgene expression. LCR cassettes composed of 5 HS2-4 linked to
the 815 bp -globin proximal promoter do not express fully. Here, we
show that LCR (5HS2-4) -globin transgenes that also
contain either 5HS1 or the distal promoter fail to express fully in single- and low-copy transgenic mice. In contrast, full expression is obtained in the presence of both 5HS1 and the
distal promoter. Nine factor binding sites were identified in
5HS1, using in vitro DNaseI footprint and gel retardation
assays, and these include a strong Sp1/Sp3 site, four GATA-1 sites, and
two sites that encompass an ACTAAC motif. LCR (5HS1-4)
-globin transgene constructs with the distal promoter deleted or
replaced by spacer DNA show that specific distal promoter sequences are
required for full expression. An LCR (5HS1-4) transgene
construct with truncated downstream -globin gene sequences indicates
that 3 sequences also play an important role. These results show
that full expression of the -globin gene directed by the LCR
requires 5HS1, the distal -globin promoter, and 3
sequences, and has implications for gene therapy construct design and
models of LCR activation.
Blood, Vol. 92 No. 2 (July 15), 1998:
pp. 653-663
© 1998 by the American Society of Hematology.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
L. Lisowski and M. Sadelain
Locus control region elements HS1 and HS4 enhance the therapeutic efficacy of globin gene transfer in -thalassemic mice
Blood,
December 15, 2007;
110(13):
4175 - 4178.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Buzina, M. I. Aladjem, J. L. Kolman, G. M. Wahl, and J. Ellis
Initiation of DNA replication at the human {beta}-globin 3' enhancer
Nucleic Acids Res.,
August 5, 2005;
33(14):
4412 - 4424.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Puthenveetil, J. Scholes, D. Carbonell, N. Qureshi, P. Xia, L. Zeng, S. Li, Y. Yu, A. L Hiti, J.-K. Yee, et al.
Successful correction of the human {beta}-thalassemia major phenotype using a lentiviral vector
Blood,
December 1, 2004;
104(12):
3445 - 3453.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. C. Ostermeier, Z. Liu, R. P. Martins, R. R. Bharadwaj, J. Ellis, S. Draghici, and S. A. Krawetz
Nuclear matrix association of the human {beta}-globin locus utilizing a novel approach to quantitative real-time PCR
Nucleic Acids Res.,
June 15, 2003;
31(12):
3257 - 3266.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Zhou and C.-M. Chiang
Sp1 and AP2 regulate but do not constitute TATA-less human TAFII55 core promoter activity
Nucleic Acids Res.,
October 1, 2002;
30(19):
4145 - 4157.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Hanazono, K. Terao, and K. Ozawa
Gene Transfer into Nonhuman Primate Hematopoietic Stem Cells: Implications for Gene Therapy
Stem Cells,
January 1, 2001;
19(1):
12 - 23.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
J. E. Rubin, P. Pasceri, X. Wu, P. Leboulch, and J. Ellis
Locus control region activity by 5'HS3 requires a functional interaction with beta -globin gene regulatory elements: expression of novel beta /gamma -globin hybrid transgenes
Blood,
May 15, 2000;
95(10):
3242 - 3249.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. S. Osborne, P. Pasceri, R. Singal, T. Sukonnik, G. D. Ginder, and J. Ellis
Amelioration of Retroviral Vector Silencing in Locus Control Region beta -Globin-Transgenic Mice and Transduced F9 Embryonic Cells
J. Virol.,
July 1, 1999;
73(7):
5490 - 5496.
[Abstract]
[Full Text]
|
|
|
|
|
